Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fatty acid oxidation disorders: outcome and long-term prognosis.

Journal of inherited metabolic disease - 1 Oct 2010

Wilcken Bridget

Abstract excerpt

Assessing the outcome of fatty acid oxidation disorders is difficult, as most are rare. For diagnosis by newborn screening, the situation is compounded: far more cases are diagnosed by screening than by clinical presentation, representing a somewhat different cohort. The literature on outcome was reviewed. For disorders other than medium-chain acyl-coenzyme A (CoA) dehydrogenase (MCAD) deficiency there was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Energy Metabolism
Share to Fatty Acids
Share to Lipid Metabolism, Inborn Errors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mitochondria

Share to Mitochondrial Diseases

Share to Oxidation-Reduction

Share to Time Factors

Share to Treatment Outcome

Source

Identifiers

PMID: 20049534
DOI: 10.1007/s10545-009-9001-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fatty acid oxidation disorders: outcome and long-term prognosis.PMID 20049534Read ↗

Late-onset multiple acyl-CoA dehydrogenase deficiency: an insidious presentation.Semantic proximity Read ↗

Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.Semantic proximity Read ↗

Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting.Semantic proximity Read ↗

Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency.Semantic proximity Read ↗

Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disordersSemantic proximity Read ↗

The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population.Semantic proximity Read ↗

Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening.Semantic proximity Read ↗

Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.Semantic proximity Read ↗

A severe genotype with favourable outcome in very long chain acyl-CoA dehydrogenase deficiency.Semantic proximity Read ↗

Urgent metabolic service improves survival in long‐chain 3‐hydroxyacyl‐CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot newborn screeningSemantic proximity Read ↗

VLCAD deficiency: Follow-up and outcome of patients diagnosed through newborn screening in Victoria.Semantic proximity Read ↗

Medium-chain acyl-CoA dehydrogenase deficiency: sudden and unexpected death of a 45 year old woman.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.